APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Rabies Vaccine

Rabies vaccine is an active immunizing agent used to prevent infection caused by the rabies virus. The vaccine works by causing your body to produce its own protection (antibodies) against the rabies virus.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Rabies vaccine is an active immunizing agent used to prevent infection caused by the rabies virus. The vaccine works by causing your body to produce its own protection (antibodies) against the rabies virus.

Selected research

Industry Growth & Trends

Global Rabies Vaccine Industry Growth and Trends Forecast to 2032

Report ID 174030490121 December 202592 pages

Choose your research edition.

Industry ResearchRabies Vaccine Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Rabies Vaccine Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Rabies Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Rabies Vaccine Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Rabies Vaccine Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

Rabies vaccine is an active immunizing agent used to prevent infection caused by the rabies virus. The vaccine works by causing your body to produce its own protection (antibodies) against the rabies virus.

Global Rabies Vaccine key players include Chengda, Changsheng, Prcmise, VACN, etc. Global top four manufacturers hold a share about 70%.

China is the largest market, with a share about 85%, followed by Europe, and North America, both have a share over 10 percent.

Read the full market overview

In terms of product, Vero Cell Rabies Vaccine is the largest segment, with a share over 75%. And in terms of application, the largest application is Post-exposure Prophylaxis, followed by Pre-exposure Prophylaxis.

Report Scope

This report provides a structured, data-driven view of the global Rabies Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Rabies Vaccine market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Rabies Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Rabies Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Rabies Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Rabies Vaccine Market by Company

GSK (Novartis)

Sanofi-Pasteur

Chengda

Yisheng

Prcmise

VACN

Changsheng

BCHT

Hissen

Rabies Vaccine Segment by Type

Vero Cell Rabies Vaccine

BHK

Chick Embryo Cell Rabies Vaccine

Others

Rabies Vaccine Segment by Application

Pre-exposure Prophylaxis

Post-exposure Prophylaxis

Rabies Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rabies Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Rabies Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rabies Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Rabies Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Rabies Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Vero Cell Rabies Vaccine Table 2. Major Company of BHK Table 3. Major Company of Chick Embryo Cell Rabies Vaccine Table 4. Major Company of Others Table 5. Global Rabies Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Rabies Vaccine Sales by Type (2021-2026) & (K Units) Table 7. Global Rabies Vaccine Sales Market Share in Volume by Type (2021-2026) Table 8. Global Rabies Vaccine Sales by Type (2021-2026) & (US$ Million) Table 9. Global Rabies Vaccine Sales Market Share in Value by Type (2021-2026) Table 10. Global Rabies Vaccine Price by Type (2021-2026) & (USD/Unit) Table 11. Global Rabies Vaccine Sales by Type (2027-2032) & (K Units) Table 12. Global Rabies Vaccine Sales Market Share in Volume by Type (2027-2032) Table 13. Global Rabies Vaccine Sales by Type (2027-2032) & (US$ Million) Table 14. Global Rabies Vaccine Sales Market Share in Value by Type (2027-2032) Table 15. Global Rabies Vaccine Price by Type (2027-2032) & (USD/Unit) Table 16. North America Rabies Vaccine Sales by Type (2021-2026) & (K Units) Table 17. North America Rabies Vaccine Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Rabies Vaccine Sales by Type (2021-2026) & (K Units) Table 19. Europe Rabies Vaccine Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Rabies Vaccine Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Rabies Vaccine Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Rabies Vaccine Sales by Type (2021-2026) & (K Units) Table 23. Latin America Rabies Vaccine Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Rabies Vaccine Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Rabies Vaccine Sales by Type (2021-2026) & (US$ Million) Table 26. Rabies Vaccine Industry Trends Table 27. Rabies Vaccine Industry Drivers Table 28. Rabies Vaccine Industry Opportunities and Challenges Table 29. Rabies Vaccine Industry Restraints Table 30. Global Rabies Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Rabies Vaccine Revenue Market Share by Company (2021-2026) Table 32. Global Rabies Vaccine Sales by Company (2021-2026) & (K Units) Table 33. Global Rabies Vaccine Sales Share by Company (2021-2026) Table 34. Global Rabies Vaccine Market Price by Company (2021-2026) & (USD/Unit) Table 35. Global Rabies Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Rabies Vaccine Major Company Production Sites and Headquarters Table 37. Global Rabies Vaccine Company, Product Type & Application Table 38. Global Rabies Vaccine Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Rabies Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Rabies Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Rabies Vaccine Sales by Region (2021-2026) & (K Units) Table 43. Global Rabies Vaccine Sales Market Share in Volume by Region (2021-2026) Table 44. Global Rabies Vaccine Sales by Region (2021-2026) & (US$ Million) Table 45. Global Rabies Vaccine Sales Market Share in Value by Region (2021-2026) Table 46. Global Rabies Vaccine Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 47. Global Rabies Vaccine Sales by Region (2027-2032) & (K Units) Table 48. Global Rabies Vaccine Sales Market Share in Volume by Region (2027-2032) Table 49. Global Rabies Vaccine Sales by Region (2027-2032) & (US$ Million) Table 50. Global Rabies Vaccine Sales Market Share in Value by Region (2027-2032) Table 51. Global Rabies Vaccine Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2027-2032) Table 52. Global Rabies Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Rabies Vaccine Sales by Application (2021-2026) & (K Units) Table 54. Global Rabies Vaccine Sales Market Share in Volume by Application (2021-2026) Table 55. Global Rabies Vaccine Sales by Application (2021-2026) & (US$ Million) Table 56. Global Rabies Vaccine Sales Market Share in Value by Application (2021-2026) Table 57. Global Rabies Vaccine Price by Application (2021-2026) & (USD/Unit) Table 58. Global Rabies Vaccine Sales by Application (2027-2032) & (K Units) Table 59. Global Rabies Vaccine Sales Market Share in Volume by Application (2027-2032) Table 60. Global Rabies Vaccine Sales by Application (2027-2032) & (US$ Million) Table 61. Global Rabies Vaccine Sales Market Share in Value by Application (2027-2032) Table 62. Global Rabies Vaccine Price by Application (2027-2032) & (USD/Unit) Table 63. North America Rabies Vaccine Sales by Application (2021-2026) & (K Units) Table 64. North America Rabies Vaccine Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Rabies Vaccine Sales by Application (2021-2026) & (K Units) Table 66. Europe Rabies Vaccine Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Rabies Vaccine Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Rabies Vaccine Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Rabies Vaccine Sales by Application (2021-2026) & (K Units) Table 70. Latin America Rabies Vaccine Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Rabies Vaccine Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Rabies Vaccine Sales by Application (2021-2026) & (US$ Million) Table 73. GSK (Novartis) Company Information Table 74. GSK (Novartis) Business Overview Table 75. GSK (Novartis) Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 76. GSK (Novartis) Rabies Vaccine Product Portfolio Table 77. GSK (Novartis) Recent Development Table 78. Sanofi-Pasteur Company Information Table 79. Sanofi-Pasteur Business Overview Table 80. Sanofi-Pasteur Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 81. Sanofi-Pasteur Rabies Vaccine Product Portfolio Table 82. Sanofi-Pasteur Recent Development Table 83. Chengda Company Information Table 84. Chengda Business Overview Table 85. Chengda Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 86. Chengda Rabies Vaccine Product Portfolio Table 87. Chengda Recent Development Table 88. Yisheng Company Information Table 89. Yisheng Business Overview Table 90. Yisheng Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 91. Yisheng Rabies Vaccine Product Portfolio Table 92. Yisheng Recent Development Table 93. Prcmise Company Information Table 94. Prcmise Business Overview Table 95. Prcmise Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 96. Prcmise Rabies Vaccine Product Portfolio Table 97. Prcmise Recent Development Table 98. VACN Company Information Table 99. VACN Business Overview Table 100. VACN Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 101. VACN Rabies Vaccine Product Portfolio Table 102. VACN Recent Development Table 103. Changsheng Company Information Table 104. Changsheng Business Overview Table 105. Changsheng Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 106. Changsheng Rabies Vaccine Product Portfolio Table 107. Changsheng Recent Development Table 108. BCHT Company Information Table 109. BCHT Business Overview Table 110. BCHT Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 111. BCHT Rabies Vaccine Product Portfolio Table 112. BCHT Recent Development Table 113. Hissen Company Information Table 114. Hissen Business Overview Table 115. Hissen Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 116. Hissen Rabies Vaccine Product Portfolio Table 117. Hissen Recent Development Table 118. North America Rabies Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 119. North America Rabies Vaccine Sales by Country (2021-2026) & (K Units) Table 120. North America Rabies Vaccine Sales Market Share by Country (2021-2026) Table 121. North America Rabies Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 122. North America Rabies Vaccine Sales Market Share Forecast by Country (2027-2032) Table 123. North America Rabies Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. North America Rabies Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 125. North America Rabies Vaccine Market Share by Country (2021-2026) Table 126. North America Rabies Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. North America Rabies Vaccine Market Share Forecast by Country (2027-2032) Table 128. Europe Rabies Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 129. Europe Rabies Vaccine Sales by Country (2021-2026) & (K Units) Table 130. Europe Rabies Vaccine Sales Market Share by Country (2021-2026) Table 131. Europe Rabies Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 132. Europe Rabies Vaccine Sales Market Share Forecast by Country (2027-2032) Table 133. Europe Rabies Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Europe Rabies Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 135. Europe Rabies Vaccine Market Share by Country (2021-2026) Table 136. Europe Rabies Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Europe Rabies Vaccine Market Share Forecast by Country (2027-2032) Table 138. Asia-Pacific Rabies Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 139. Asia-Pacific Rabies Vaccine Sales by Country (2021-2026) & (K Units) Table 140. Asia-Pacific Rabies Vaccine Sales Market Share by Country (2021-2026) Table 141. Asia-Pacific Rabies Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 142. Asia-Pacific Rabies Vaccine Sales Market Share Forecast by Country (2027-2032) Table 143. Asia-Pacific Rabies Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Asia-Pacific Rabies Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 145. Asia-Pacific Rabies Vaccine Market Share by Country (2021-2026) Table 146. Asia-Pacific Rabies Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Asia-Pacific Rabies Vaccine Market Share Forecast by Country (2027-2032) Table 148. Latin America Rabies Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 149. Latin America Rabies Vaccine Sales by Country (2021-2026) & (K Units) Table 150. Latin America Rabies Vaccine Sales Market Share by Country (2021-2026) Table 151. Latin America Rabies Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 152. Latin America Rabies Vaccine Sales Market Share Forecast by Country (2027-2032) Table 153. Latin America Rabies Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Latin America Rabies Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 155. Latin America Rabies Vaccine Market Share by Country (2021-2026) Table 156. Latin America Rabies Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Latin America Rabies Vaccine Market Share Forecast by Country (2027-2032) Table 158. Middle East and Africa Rabies Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 159. Middle East and Africa Rabies Vaccine Sales by Country (2021-2026) & (K Units) Table 160. Middle East and Africa Rabies Vaccine Sales Market Share by Country (2021-2026) Table 161. Middle East and Africa Rabies Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 162. Middle East and Africa Rabies Vaccine Sales Market Share Forecast by Country (2027-2032) Table 163. Middle East and Africa Rabies Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Middle East and Africa Rabies Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 165. Middle East and Africa Rabies Vaccine Market Share by Country (2021-2026) Table 166. Middle East and Africa Rabies Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Middle East and Africa Rabies Vaccine Market Share Forecast by Country (2027-2032) Table 168. Key Raw Materials Table 169. Raw Materials Key Suppliers Table 170. Rabies Vaccine Distributors List Table 171. Rabies Vaccine Customers List Table 172. Research Programs/Design for This Report Table 173. Authors List of This Report Table 174. Secondary Sources Table 175. Primary Sources List of Figures Figure 1. Rabies Vaccine Image Figure 2. Global Rabies Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Rabies Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Rabies Vaccine Sales (2021-2032) & (K Units) Figure 5. Vero Cell Rabies Vaccine Image Figure 6. Global Vero Cell Rabies Vaccine Sales YoY Growth (2021-2032) & (K Units) Figure 7. BHK Image Figure 8. Global BHK Sales YoY Growth (2021-2032) & (K Units) Figure 9. Chick Embryo Cell Rabies Vaccine Image Figure 10. Global Chick Embryo Cell Rabies Vaccine Sales YoY Growth (2021-2032) & (K Units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Rabies Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Rabies Vaccine Market Share by Type 2025 VS 2032 Figure 15. North America Rabies Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. North America Rabies Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Europe Rabies Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Europe Rabies Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Rabies Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Rabies Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Latin America Rabies Vaccine Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Rabies Vaccine Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Rabies Vaccine Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Rabies Vaccine Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Rabies Vaccine Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Pre-exposure Prophylaxis Image Figure 28. Global Pre-exposure Prophylaxis Sales YoY Growth (2021-2032) & (K Units) Figure 29. Post-exposure Prophylaxis Image Figure 30. Global Post-exposure Prophylaxis Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Rabies Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Rabies Vaccine Market Share by Application 2025 VS 2032 Figure 33. North America Rabies Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. North America Rabies Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Europe Rabies Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Europe Rabies Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Rabies Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Rabies Vaccine Sales Market Share in Value by Application in 2025 Figure 39. Latin America Rabies Vaccine Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Rabies Vaccine Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Rabies Vaccine Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Rabies Vaccine Sales Market Share in Value by Application in 2025 Figure 43. North America Rabies Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Rabies Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Rabies Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Rabies Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Rabies Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Rabies Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Rabies Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Rabies Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Rabies Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Rabies Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Rabies Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Rabies Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Rabies Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Rabies Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Rabies Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Rabies Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Rabies Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Rabies Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Rabies Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Rabies Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Rabies Vaccine Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Rabies Vaccine Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Vero Cell Rabies Vaccine
  • BHK
  • Chick Embryo Cell Rabies Vaccine
  • Others
Applications
  • Pre-exposure Prophylaxis
  • Post-exposure Prophylaxis
Companies covered
  • GSK (Novartis)
  • Sanofi-Pasteur
  • Chengda
  • Yisheng
  • Prcmise
  • VACN
  • Changsheng
  • BCHT
  • Hissen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Rabies Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Rabies Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Rabies Vaccine Market by Type
  6. 1.3.1 Vero Cell Rabies Vaccine
  7. 1.3.2 BHK
  8. 1.3.3 Chick Embryo Cell Rabies Vaccine
  9. 1.3.4 Others
  10. 1.4 Global Rabies Vaccine Market Size by Type
  11. 1.4.1 Global Rabies Vaccine Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Rabies Vaccine Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Rabies Vaccine Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Rabies Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Rabies Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Rabies Vaccine Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Rabies Vaccine Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Rabies Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Rabies Vaccine Industry Trends
  2. 2.2 Rabies Vaccine Industry Drivers
  3. 2.3 Rabies Vaccine Industry Opportunities and Challenges
  4. 2.4 Rabies Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Rabies Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Rabies Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Rabies Vaccine Price (2021-2026)
  4. 3.4 Global Rabies Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Rabies Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Rabies Vaccine Company, Product Type & Application
  7. 3.7 Global Rabies Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Rabies Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Rabies Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Rabies Vaccine Tier 1, Tier 2, and Tier 3
4 Rabies Vaccine Regional Status and Outlook
  1. 4.1 Global Rabies Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Rabies Vaccine Historic Market Size by Region
  3. 4.2.1 Global Rabies Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Rabies Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Rabies Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Rabies Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Rabies Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Rabies Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Rabies Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Rabies Vaccine by Application
  1. 5.1 Rabies Vaccine Market by Application
  2. 5.1.1 Pre-exposure Prophylaxis
  3. 5.1.2 Post-exposure Prophylaxis
  4. 5.2 Global Rabies Vaccine Market Size by Application
  5. 5.2.1 Global Rabies Vaccine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Rabies Vaccine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Rabies Vaccine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Rabies Vaccine Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Rabies Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Rabies Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Rabies Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Rabies Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 GSK (Novartis)
  2. 6.1.1 GSK (Novartis) Company Information
  3. 6.1.2 GSK (Novartis) Business Overview
  4. 6.1.3 GSK (Novartis) Rabies Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 GSK (Novartis) Rabies Vaccine Product Portfolio
  6. 6.1.5 GSK (Novartis) Recent Developments
  7. 6.2 Sanofi-Pasteur
  8. 6.2.1 Sanofi-Pasteur Company Information
  9. 6.2.2 Sanofi-Pasteur Business Overview
  10. 6.2.3 Sanofi-Pasteur Rabies Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi-Pasteur Rabies Vaccine Product Portfolio
  12. 6.2.5 Sanofi-Pasteur Recent Developments
  13. 6.3 Chengda
  14. 6.3.1 Chengda Company Information
  15. 6.3.2 Chengda Business Overview
  16. 6.3.3 Chengda Rabies Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Chengda Rabies Vaccine Product Portfolio
  18. 6.3.5 Chengda Recent Developments
  19. 6.4 Yisheng
  20. 6.4.1 Yisheng Company Information
  21. 6.4.2 Yisheng Business Overview
  22. 6.4.3 Yisheng Rabies Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Yisheng Rabies Vaccine Product Portfolio
  24. 6.4.5 Yisheng Recent Developments
  25. 6.5 Prcmise
  26. 6.5.1 Prcmise Company Information
  27. 6.5.2 Prcmise Business Overview
  28. 6.5.3 Prcmise Rabies Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Prcmise Rabies Vaccine Product Portfolio
  30. 6.5.5 Prcmise Recent Developments
  31. 6.6 VACN
  32. 6.6.1 VACN Company Information
  33. 6.6.2 VACN Business Overview
  34. 6.6.3 VACN Rabies Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 VACN Rabies Vaccine Product Portfolio
  36. 6.6.5 VACN Recent Developments
  37. 6.7 Changsheng
  38. 6.7.1 Changsheng Company Information
  39. 6.7.2 Changsheng Business Overview
  40. 6.7.3 Changsheng Rabies Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Changsheng Rabies Vaccine Product Portfolio
  42. 6.7.5 Changsheng Recent Developments
  43. 6.8 BCHT
  44. 6.8.1 BCHT Company Information
  45. 6.8.2 BCHT Business Overview
  46. 6.8.3 BCHT Rabies Vaccine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 BCHT Rabies Vaccine Product Portfolio
  48. 6.8.5 BCHT Recent Developments
  49. 6.9 Hissen
  50. 6.9.1 Hissen Company Information
  51. 6.9.2 Hissen Business Overview
  52. 6.9.3 Hissen Rabies Vaccine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Hissen Rabies Vaccine Product Portfolio
  54. 6.9.5 Hissen Recent Developments
7 North America by Country
  1. 7.1 North America Rabies Vaccine Sales by Country
  2. 7.1.1 North America Rabies Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Rabies Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Rabies Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Rabies Vaccine Market Size by Country
  6. 7.2.1 North America Rabies Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Rabies Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Rabies Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Rabies Vaccine Sales by Country
  2. 8.1.1 Europe Rabies Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Rabies Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Rabies Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Rabies Vaccine Market Size by Country
  6. 8.2.1 Europe Rabies Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Rabies Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Rabies Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Rabies Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Rabies Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Rabies Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Rabies Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Rabies Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Rabies Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Rabies Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Rabies Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Rabies Vaccine Sales by Country
  2. 10.1.1 South America Rabies Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Rabies Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Rabies Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Rabies Vaccine Market Size by Country
  6. 10.2.1 South America Rabies Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Rabies Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Rabies Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Rabies Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Rabies Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Rabies Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Rabies Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Rabies Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Rabies Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Rabies Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Rabies Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Rabies Vaccine Value Chain Analysis
  2. 12.1.1 Rabies Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Rabies Vaccine Production Mode & Process
  7. 12.2 Rabies Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Rabies Vaccine Distributors
  10. 12.2.3 Rabies Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst